Reflect Scientific Inc. Letter to Shareholders
Reflect Scientific, Inc. (RSCF) shares insights from CEO Kim Boyce, detailing developments in cryogenic temperature control systems. Over ten years, the company has improved its non-mechanical systems, enhancing reliability and cost-effectiveness. Key products include the Cryometrix S-90 shipper, and interest is growing in applications for vaccine management and air freight. Reflect Scientific remains debt-free and filed a Form 10 Registration Statement with the SEC to become a fully-reporting issuer. The outlook is bullish as the company continues to receive inquiries from government and major corporations like Boeing and NASA.
- Continued customer interest in product lines due to unique capabilities.
- Debt-free status indicates financial stability.
- Growing inquiries from major clients including government agencies, Boeing, and NASA.
- None.
OREM, Utah, May 17, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces a shareholder message from the CEO.
A shareholder message from Kim Boyce, CEO of Reflect Scientific Inc.:
As mentioned in my previous press release, Reflect Scientific Inc. started developing cryogenic temperature control systems based on liquid nitrogen over ten years ago. Over time many improvements have been made and a large body of intellectual property created. We have also allied with a manufacturing facility capable of producing our systems in large volume.
There continues to be growing interest in our product lines due to their unique capabilities to support the processing, storage, and transportation needs of a wide range of life science sectors, including Biologics/CGT, Blood, and Vaccines.
Several factors essentially drive customer interest:
- Non-mechanical systems, exceptional reliability, cost-effectiveness
- Superior temperature control anywhere from ambient to – 160 deg C
- Cryometrix S-90 cryogenic shipper can run off the grid for long periods of time
- Green technology
In processing applications, we continue to receive orders for our B-90 blast freezing system and now have many units in operation, the performance of which has met or exceeded expectations. Feedback has shown customers have realized a significant benefit from their use.
In the Storage arena, we continue to sell our T-90 and T-160 products. We have recently received an inquiry from a major government agency looking for non-mechanical freezers to supplant many of their existing mechanical units.
In the transportation/cold chain area, we continue to receive inquiries for the following applications:
- Vaccine management
- Air freight temperature-controlled containers
- Use of our CB 40 system for TRU reefers – a recent message from CARB indicates we are the leading choice of technology for California markets
In addition, we have received inquiries for broader applications for our L-80 chiller systems from Boeing and NASA.
Our outlook for Reflect Scientific continues to remain bullish. The Company continues to be debt-free.
On March 30, 2021, Reflect Scientific filed a Form 10 Registration Statement with the SEC. Upon effectiveness of Form 10, Reflect will become a ‘fully-reporting issuer’ with the SEC. Among other things, this means that we will resume filing Annual Reports on Form 10-K and Quarterly Reports on 10-Q with the SEC regularly. Our year-end financial results are available for review in Form 10, which is available on the SEC’s website, and they are also available on the OTC Markets website.
For more announcements, keep an eye on our website www.reflectscientific.com and www.finance.yahoo.com, ticker symbol RSCF.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit www.reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”
FAQ
What recent developments has Reflect Scientific announced regarding RSCF?
What is the significance of the Form 10 Registration Statement filed by RSCF?
How is Reflect Scientific addressing the needs of the vaccine management market?
What is the outlook for Reflect Scientific as mentioned in the press release?
